A call for better depression treatment in people with Parkinson disease
Citation Manager Formats
Make Comment
See Comments
![Loading Loading](https://n.neurology.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Although long established as a quintessential movement disorder, Parkinson disease (PD) is increasingly recognized as a complex neuropsychiatric condition. In fact, more people with PD (PWP) have at least one neuropsychiatric symptom, such as anxiety, apathy, cognitive impairment, depression, or psychosis, than have rest tremor. Depression alone affects half of all PWP and is one of the most important factors affecting quality of life over the course of the disease.1 Depression also compounds disability in PWP, leading to more rapid mental and physical decline and greater impairment in activities of daily living, resulting in greater burden on caregivers, health care services, and the economy.2,3 Treating depression using an interdisciplinary approach is therefore an essential part of the overall management of PD.
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 702
- © 2020 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jessica Ailani and Dr. Ailna Masters-Israilov
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Review
A practical approach to detection and treatment of depression in Parkinson disease and dementiaZahra Goodarzi, Zahinoor Ismail et al.Neurology: Clinical Practice, March 24, 2017 -
Article
Telephone-based cognitive behavioral therapy for depression in Parkinson diseaseA randomized controlled trialRoseanne D. Dobkin, Sarah L. Mann, Michael A. Gara et al.Neurology, April 01, 2020 -
Articles
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson diseaseD. Weintraub, S. Mavandadi, E. Mamikonyan et al.Neurology, August 02, 2010 -
Articles
Dissociating apathy and depression in Parkinson diseaseL. Kirsch-Darrow, H. F. Fernandez, M. Marsiske et al.Neurology, July 10, 2006